Coronavirus Outbreak: ESIC further extends period for filing ESI contributions for February till 15 May

The Employees' State Insurance Corporation (ESIC) has further extended the deadline for filing ESI contributions for February till 15 May in view of the coronavirus lockdown

Press Trust of India April 14, 2020 17:53:31 IST
Coronavirus Outbreak: ESIC further extends period for filing ESI contributions for February till 15 May

New Delhi: The Employees' State Insurance Corporation (ESIC) has further extended the deadline for filing ESI contributions for February till 15 May in view of the coronavirus lockdown.

Earlier, the ESIC had extended the period for filing contributions for the months of February and March till 15 April and 15 May respectively.

Prime Minister Narendra Modi on Tuesday announced extending the nationwide lockdown till 3 May.

Coronavirus Outbreak ESIC further extends period for filing ESI contributions for February till 15 May

Representational image. Reuters.

Explaining the reasons for extending the period for filing ESI contributions, the Labour Ministry in a statement said many establishments are temporarily closed and workers are unable to work due to the COVID-19 crisis.

In line with the relief measures being extended by the government to business entities and workers, ESIC has taken steps for its stakeholders, specially employers and insured persons, besides strengthening its medical resources to fight COVID-19, it added.

As a relief measure, the period for filing ESI contribution for the months of February and March was earlier extended April 15 and May 15, respectively.

Now, considering the hardship being faced by employers, the period for filing ESI contribution for the month of February has been further extended to May 15, 2020, it stated.

The period for filing contribution for March is also 15 May.

No penalty or interest will be levied on establishments during the extended period. Around 3.49 crore insured persons (IPs) and 12,11,174 employers will get relief with the extension of period for filing the return, it added.

Besides these, some more relief measures have been undertaken for IPs and beneficiaries.

Purchase of medicines by ESI beneficiaries from private chemists during the lockdown period and its subsequent reimbursement by ESIC has been permitted, it said.

A provision has also been made for providing medical services to IPs and beneficiaries from tie-up hospitals, if an ESIC hospital is declared as a dedicated Covid-19 facility.

A medical benefit is provided under Rule 60-61 to the IPs who cease to be in insurable employment on account of permanent disablement and to the retired IPs on payment of advance lump-sum contribution for a year at the rate of Rs 10 per month.

Under the prevailing circumstances of lockdown, there may be cases where validity of the medical benefit cards issued to these beneficiaries expire as they are unable to deposit the advance annual lump-sum contribution.

Such beneficiaries have been allowed to avail medical benefit under Rule 60 and 61 of ESI (Central Rules) till 30 June, 2020, it said.

Payment of about Rs 41 crore in respect of permanent disablement benefit and dependants' benefit has been sent to the bank accounts of beneficiaries in the month of March 2020, it said.

Updated Date:

also read

COVID-19 update: India reports 2,841 new cases, nine deaths in last 24 hours, active cases dip to 18,604
India

COVID-19 update: India reports 2,841 new cases, nine deaths in last 24 hours, active cases dip to 18,604

The fresh COVID-19 infections reported on Friday were marginally higher than 2,827 cases logged on Thursday. The daily positivity rate was recorded at 0.58 per cent, while the weekly positivity rate was 0.69 per cent

India logs 2,202 new COVID-19 cases in last 24 hours, down 11.45% from day ago; daily positivity rate up at 0.74%
India

India logs 2,202 new COVID-19 cases in last 24 hours, down 11.45% from day ago; daily positivity rate up at 0.74%

India now has 17,317 active cases of COVID-19, a decline of 375 cases in the active caseload in a span of 24 hours. The active cases now comprise of 0.04 per cent of the total infections

SII seeks permission for next trial of Covovax as booster dose in children aged 2 to 18 years
India

SII seeks permission for next trial of Covovax as booster dose in children aged 2 to 18 years

The Drugs Controller General of India (DCGI) had granted permission in March for conducting Phase-3 clinical trial of Covovax as a booster dose in adults